Is EPAM Systems (EPAM) a risky stock?
As of July 21, 2026, Clavix grades EPAM Systems (EPAM) B- for risk, a composite score of 70 out of 100 on an A+ to F scale, which puts EPAM in the "solid" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind EPAM's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how EPAM scores on each, as of July 21, 2026.
What's moving EPAM's risk right now
Company-specific signals Clavix flags behind EPAM's current grade, drawn from recent news and filings as of July 21, 2026.
An rating cut EPAM's price target by 27%, pointing to weaker near-term earnings expectations. The reduction reflects broad estimate cuts across the sector rather than company-specific problems.
EPAM's stock has fallen 85% over the long term, leaving shares trading at a low valuation. But the gap between share price and business performance shows investors still have unresolved concerns.
A Zacks-style screen suggests EPAM may be trading below its estimated fair value. That could point to a buying opportunity, though it's just one screen-based signal, not a confirmed catalyst.
What a B- grade means
On the Clavix A+ to F scale, EPAM's composite of 70 falls in the B band (65–79), read as "solid." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell EPAM or any security. Grades are risk indicators, not predictions of return. Data may be delayed.